Table 3.
Incidence rate ratio (IRR) of bullous pemphigoid (BP) with the prescription of DPP4 inhibitors based on MarketScan data.
| DPP4 inhibitors | BP cases | Incidence rate (% per person-year) | IRR (95% CI) | Z score | –log10 p |
|---|---|---|---|---|---|
| + | 179/112,549 | 0.148 | 1.68 (1.45–1.95) | 6.93 | 11.4 |
| – | 40,874/31,336,175 | 0.088 |